| __timestamp | Eli Lilly and Company | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 14683100000 | 580006000 |
| Thursday, January 1, 2015 | 14921500000 | 676585000 |
| Friday, January 1, 2016 | 15567200000 | 778966000 |
| Sunday, January 1, 2017 | 16801100000 | 671251000 |
| Monday, January 1, 2018 | 16811600000 | 463508000 |
| Tuesday, January 1, 2019 | 17598300000 | 445724000 |
| Wednesday, January 1, 2020 | 19056500000 | 399725000 |
| Friday, January 1, 2021 | 21005600000 | 296656000 |
| Saturday, January 1, 2022 | 21911600000 | 293122000 |
| Sunday, January 1, 2023 | 27041900000 | 268323000 |
| Monday, January 1, 2024 | 36624400001 | 304979000 |
Data in motion
In the competitive world of pharmaceuticals, gross profit is a key indicator of a company's financial health and market prowess. Over the past decade, Eli Lilly and Company has consistently outperformed Taro Pharmaceutical Industries Ltd. in terms of gross profit. From 2014 to 2023, Eli Lilly's gross profit surged by approximately 84%, peaking at a staggering $27 billion in 2023. In contrast, Taro's gross profit saw a decline, dropping to around $268 million in the same year, marking a decrease of over 50% from its 2016 peak.
This stark contrast highlights Eli Lilly's robust growth trajectory and market dominance, while Taro faces challenges in maintaining its profitability. The data underscores the importance of strategic innovation and market adaptation in the pharmaceutical industry, where financial performance can vary significantly between competitors.
Eli Lilly and Company vs Novartis AG: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Eli Lilly and Company vs Zoetis Inc.
Eli Lilly and Company and Bristol-Myers Squibb Company: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Eli Lilly and Company and Walgreens Boots Alliance, Inc.
Key Insights on Gross Profit: Eli Lilly and Company vs MorphoSys AG
Gross Profit Comparison: Eli Lilly and Company and Evotec SE Trends
Gross Profit Analysis: Comparing Eli Lilly and Company and MiMedx Group, Inc.
Novo Nordisk A/S vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Taro Pharmaceutical Industries Ltd.
Who Generates Higher Gross Profit? Bio-Techne Corporation or Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Catalent, Inc. and Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Vericel Corporation and Taro Pharmaceutical Industries Ltd.